Enhancement of Antibody Titre and Development of Additional Red Cell Alloantibodies Following Intrauterine Transfusion

[1]  D. Roelen,et al.  High anti‐HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother–child HLA triplet mismatches, high anti‐D titer, and new red blood cell antibody formation , 2013, Transfusion.

[2]  C. Hillyer,et al.  Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. , 2007, Blood.

[3]  F. Klumper,et al.  High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. , 2007, American journal of obstetrics and gynecology.

[4]  W. Poole,et al.  Trends in neonatal morbidity and mortality for very low birthweight infants. , 2007, American journal of obstetrics and gynecology.

[5]  C. Hillyer,et al.  Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells , 2006, Transfusion.

[6]  J. Wax,et al.  Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease. , 2006, American journal of perinatology.

[7]  A. Brand,et al.  Induction of additional red cell alloantibodies after intrauterine transfusions , 1994, Transfusion.

[8]  P. Hanfland,et al.  [Antibody induction after intrauterine interventions]. , 1993, Infusionstherapie und Transfusionsmedizin.

[9]  C. Rodeck,et al.  Consequences of fetomaternal haemorrhage after intrauterine transfusion. , 1988, BMJ.

[10]  R. Romero,et al.  Taking the American Journal of Obstetrics & Gynecology into the 21st century. , 2007, American journal of obstetrics and gynecology.

[11]  P. Hanfland,et al.  [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis]. , 1992, Beitrage zur Infusionstherapie = Contributions to infusion therapy.